⌘K

Login Start Free

Home/Filings/4/0001179110-13-004593

4//SEC Filing

SYNTA PHARMACEUTICALS CORP 4

Accession 0001179110-13-004593

$MDGLCIK 0001157601operating

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 6:29 PM ET

Size

5.1 KB

Accession

0001179110-13-004593

Insider Transaction Report

Form 4

Period: 2013-03-05

SYNTA PHARMACEUTICALS CORPSNTA

SVP, Chief Medical Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2013-03-05+100,000→ 100,000 total
Exercise: $9.65Exp: 2023-03-05→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The option vests as to 25% of the shares on March 5, 2014 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

SYNTA PHARMACEUTICALS CORP

CIK 0001157601

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001157601

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 6:29 PM ET
Size: 5.1 KB

View on SEC.gov